Nath Bio-Genes FY26 revenue grew 19% to ₹431.6 Cr, fueled by strong Cotton, Paddy, and Maize sales.

Nath Bio-Genes (India) LimitedNATHBIOGEN · Filed with the exchange

PBT rose 11% to ₹49.1 Cr, though PAT dipped 8% and margins compressed.

A new ₹15 Cr international topline from Uzbekistan marks significant expansion.

No comments yet. Be the first.

More from Nath Bio-Genes (India) Limited

Dividend/Bonus01-09-2026
Record Date
Others01-09-2026
Shareholders meeting
Others06-08-2026
Initiation of Forensic Audit
Updates30-07-2026
General Updates
Board Meeting29-07-2026
Outcome of Board Meeting
Others23-07-2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.